Nose to brain delivery of selegiline loaded PLGA/lipid nanoparticles : Synthesis, characterisation and brain pharmacokinetics evaluation
Parkinson's disease (PD) is the second most common progressive neurodegenerative disease that promotes neuronal cell death. The primary treatment strategy for Parkinson's disease involves the therapy of an MAO-B inhibitor molecule, selegiline. The present research aims to fabricate selegil...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English English |
| Published: |
Editions de Sante
2022
|
| Subjects: | |
| Online Access: | http://umpir.ump.edu.my/id/eprint/40195/1/Nose%20to%20brain%20delivery%20of%20selegiline%20loaded%20PLGA.pdf http://umpir.ump.edu.my/id/eprint/40195/2/Nose%20to%20brain%20delivery%20of%20selegiline%20loaded%20PLGA_lipid%20nanoparticles_Synthesis%2C%20characterisation%20and%20brain%20pharmacokinetics%20evaluation_ABS.pdf |